V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002391 | 240011170 | 1.78 | 8.6 | 03 | 2021-02-14 | 2021-02-18 | LEAM | 02 | N | IBRUTINIB | 101179262 |
| 240002408 | 240011171 | 1.71 | 80.2 | null | 2019-08-14 | 2019-08-24 | Imatinib 400mg | null | null | DABRAFENIB | 101831406 |
| 240002421 | 240011173 | 1.82 | 72.4 | null | null | 2021-10-07 | null | null | N | INOTUZUMAB OZOGAMICIN | 100148329 |
| 240002427 | 240011175 | 1.87 | 75.4 | Curative (C) | 2019-11-10 | 2019-11-11 | Carboplatin + Liposomal Doxorubicin | 02 | N | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 100828896 |
| 240002428 | 240011176 | 1.76 | 83.6 | null | 2016-11-03 | 2016-12-10 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | null | CAR-T AXICABTAGENE CILOLEUCEL + CYCLOPHOSPHAMIDE + FLUDARABINE | 101526696 |
| 240002431 | 240011178 | 1.61 | 34.8 | null | 2020-05-25 | 2020-05-25 | AML MyeChild 01 FLA-Idarubicin | 02 | null | TRANSPLANT CAR-T CELLS - AXICABTAGENE CILOLEUCEL | 101729725 |
| 240002478 | 240011180 | 1.65 | 82.3 | Curative (C) | 2018-05-22 | 2019-01-15 | CLADRIBINE | 01 | null | RITUXIMAB + VENETOCLAX | 100059700 |
| 240002487 | 240011182 | 1.5 | 63.8 | Palliative (P) | 2018-09-05 | 2018-09-05 | null | 02 | N | METHOTREXATE INTRATHECAL | 100475949 |
| 240002494 | 240011184 | 1.57 | 96.1 | null | 2020-03-26 | 2020-05-01 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | AML16 TRIAL | 101692205 |
| 240002530 | 240011185 | 1.64 | 90 | Curative (C) | 2016-07-29 | 2017-01-11 | null | 02 | N | CISPLATIN + GEMCITABINE | 101456655 |
| 240002531 | 240011186 | 1.62 | 80.8 | null | null | 2018-10-28 | AML Downs HA | null | null | CYTARABINE + IDARUBICIN | 101194161 |
| 240002533 | 240011187 | 1.85 | 17 | null | 2019-01-08 | 2019-01-15 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | DABRAFENIB | 100183101 |
| 240002573 | 240011189 | 1.62 | 71.2 | null | 2021-01-16 | 2021-01-20 | null | 02 | null | RUXOLITINIB | 100651140 |
| 240002577 | 240011190 | 1.76 | null | null | 2021-07-19 | 2021-07-23 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | TRIPLE INTRATHECAL | 101309020 |
| 240002583 | 240011191 | 1.73 | null | null | 2021-08-12 | 2021-09-23 | Etoposide Conditioning | 02 | null | RITUXIMAB + VENETOCLAX | 100560456 |
| 240002597 | 240011192 | 0 | 72.9 | null | 2018-11-10 | 2018-11-12 | null | 02 | N | CYTARABINE + DAUNORUBICIN | 101029319 |
| 240002610 | 240011193 | 1.83 | 84.8 | Curative (C) | 2020-01-05 | 2020-01-05 | AML MyeChild | 02 | N | OBINUTUZUMAB | 100238819 |
| 240002620 | 240011195 | 1.83 | 50.7 | null | null | 2020-06-22 | null | 01 | null | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 100852396 |
| 240002631 | 240011196 | 0 | 18.7 | null | 2019-07-05 | 2019-07-09 | null | 02 | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 100610839 |
| 240002657 | 240011197 | 1.63 | 62.5 | null | 2020-06-07 | 2020-12-23 | IMATINIB | 01 | null | TRANSPLANT ALEMTUZUMAB + CYCLOPHOSPHAMIDE (+/- TBI) | 100373006 |
| 240002661 | 240011199 | 1.82 | 56.8 | null | 2020-01-17 | 2020-02-13 | null | 02 | null | RUXOLITINIB | 100392129 |
| 240002691 | 240011201 | 1.62 | 21 | Palliative (P) | 2018-04-24 | 2018-06-28 | null | 02 | N | CISPLATIN + GEMCITABINE | 101090800 |
| 240002720 | 240011203 | 1.62 | 91.6 | Curative (C) | 2019-01-10 | 2019-01-22 | IMATINIB | 02 | null | FLUDARABINE + THIOTEPA + TREOSULFAN | 100130048 |
| 240002723 | 240011205 | 1.62 | 65.8 | Palliative (P) | 2022-02-03 | 2022-05-13 | Trial Unspecified | N | N | VENETOCLAX | 100079064 |
| 240002730 | 240011206 | null | 60 | Curative (C) | null | 2020-11-09 | ALL Int Guide A Ind PhI Erw | null | null | CYTARABINE HIGH DOSE | 100332081 |
| 240002757 | 240011207 | 1.8 | 17.3 | null | null | 2021-08-16 | R-GDP | null | null | RUXOLITINIB | 101368299 |
| 240002786 | 240011209 | 1.79 | 84.5 | null | 2017-09-15 | 2018-03-07 | null | 2 | null | RUXOLITINIB | 100601343 |
| 240002787 | 240011210 | 1.59 | 96.1 | null | 2022-01-29 | 2022-02-02 | AML MyeChild 01 FLA | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100469034 |
| 240002822 | 240011214 | 1.6 | 133.4 | null | null | 2018-06-06 | null | null | null | BUSULFAN | 100039410 |
| 240002831 | 240011215 | 1.67 | 96.4 | null | null | 2021-07-02 | Lenalidomide 25mg (Cycle 1 to 25) | null | null | CLADRIBINE + RITUXIMAB | 100005624 |
| 240002839 | 240011217 | 1.72 | 0 | 03 | 2019-03-04 | 2019-03-04 | Triple / Double Intrathecal Therapy | 02 | N | LEAM | 100264509 |
| 240000533 | 240011223 | 1.9 | 77.2 | null | 2020-02-07 | 2020-02-15 | null | 02 | N | ALL INT GDE 2019 MAINTENANCE | 100823555 |
| 240001015 | 240011226 | 1.75 | 70.65 | Curative (C) | 2017-05-10 | 2017-05-18 | TISAGENLECLEUCEL-T | 02 | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101156464 |
| 240001123 | 240011227 | 1.83 | null | Curative (C) | 2020-05-07 | 2020-11-20 | IBRUTINIB | null | N | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101055953 |
| 240002801 | 240011228 | 1.84 | 17.3 | null | 2018-01-14 | 2021-04-22 | null | 02 | null | RUXOLITINIB | 100815906 |
| 240000892 | 240011298 | null | null | null | null | 2019-04-21 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101841918 |
| 240000936 | 240011317 | null | null | null | null | 2018-06-02 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101506948 |
| 240000972 | 240011331 | null | null | Curative (C) | null | 2018-08-14 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101073965 |
| 240000983 | 240011334 | null | null | null | null | 2019-09-12 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101636006 |
| 240000984 | 240011335 | null | null | null | null | 2021-01-06 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101342003 |
| 240000988 | 240011336 | null | null | Palliative (P) | 2019-10-17 | 2019-10-18 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100098412 |
| 240000991 | 240011337 | null | null | 03 | null | 2022-02-07 | null | 02 | N | METHOTREXATE | 100063265 |
| 240000993 | 240011339 | null | null | null | null | 2018-12-21 | null | null | null | HYDROXYCARBAMIDE | 101389629 |
| 240000996 | 240011340 | null | null | null | null | 2019-01-31 | null | null | null | METHOTREXATE | 101352952 |
| 240001001 | 240011343 | 1.86 | 44.7 | null | 2016-09-17 | 2016-11-09 | Rituximab | 02 | N | RITUXIMAB | 101519572 |
| 240001009 | 240011344 | null | null | 03 | 2019-08-25 | 2019-08-27 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100510139 |
| 240001017 | 240011345 | 1.6 | 87.5 | null | null | 2022-03-25 | null | 02 | null | AML19 TRIAL | 101586177 |
| 240001019 | 240011346 | 1.05 | 23.8 | Curative (C) | 2019-08-03 | 2019-08-04 | Rituximab (Maintenance) | 01 | N | RITUXIMAB | 100554288 |
| 240001044 | 240011350 | 1.53 | 102.9 | null | 2017-12-01 | 2017-12-22 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101395848 |
| 240001050 | 240011351 | 1.79 | 107.5 | null | null | 2019-06-27 | null | 02 | Y | AZACITIDINE | 100771514 |